On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Conference theme: Industry meets Academia – New collaborations and Partnerships
Key focus areas: Experimental Medicine for drug development, Non-drug-based interventions and technology, Data & Omics and Clinical trials
This in-person conference is organised by the Oxford Health BRC and sponsored by the UK Mental Health Mission. The event aims to bring together industry, academic & clinical researchers, the regulator and government research funding organisations to discuss the current challenges facing therapeutic development. The overall objective is to forge collaborations that can increase capacity and capability through partnerships to deliver paradigm changes in translational mental health research. The event includes keynotes, lightning talks, roundtable discussion and industry led workshop sessions by Angelini Pharma, Big Health, Boehringer Ingelheim, Bristol Myers Squibb and Reckitt Benckiser.
